AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 33 filers reported holding AXCELLA HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,868 | -54.5% | 77,272 | 0.0% | 0.00% | – |
| Q1 2023 | $37,091 | -26.7% | 77,272 | -50.0% | 0.00% | – |
| Q4 2022 | $50,614 | -61.7% | 154,544 | +100.0% | 0.00% | – |
| Q3 2022 | $132,000 | -15.9% | 77,272 | 0.0% | 0.00% | – |
| Q2 2022 | $157,000 | -21.1% | 77,272 | 0.0% | 0.00% | – |
| Q1 2022 | $199,000 | +34.5% | 77,272 | +9.3% | 0.00% | – |
| Q4 2021 | $148,000 | -29.9% | 70,676 | 0.0% | 0.00% | – |
| Q3 2021 | $211,000 | -25.4% | 70,676 | 0.0% | 0.00% | – |
| Q2 2021 | $283,000 | -73.5% | 70,676 | -68.5% | 0.00% | – |
| Q1 2021 | $1,067,000 | -1.7% | 224,102 | +7.1% | 0.00% | – |
| Q4 2020 | $1,086,000 | +17.5% | 209,288 | +4.6% | 0.00% | – |
| Q3 2020 | $924,000 | +17.9% | 200,088 | +41.1% | 0.00% | – |
| Q2 2020 | $784,000 | +98.0% | 141,829 | +22.5% | 0.00% | – |
| Q1 2020 | $396,000 | +72.2% | 115,765 | +102.2% | 0.00% | – |
| Q4 2019 | $230,000 | – | 57,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 8,748,414 | $81,448,000 | 3.52% |
| HARBOURVEST PARTNERS LLC | 1,229,034 | $11,442,000 | 2.14% |
| Artal Group S.A. | 389,741 | $3,628,000 | 0.15% |
| HealthCor Management, L.P. | 170,645 | $1,589,000 | 0.06% |
| Schonfeld Strategic Advisors LLC | 35,000 | $326,000 | 0.01% |
| Alyeska Investment Group, L.P. | 76,062 | $708,000 | 0.01% |
| KCL Capital, L.P. | 10,000 | $93,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 13,024 | $122,000 | 0.01% |
| FMR LLC | 3,380,000 | $29,095,000 | 0.00% |
| Squarepoint Ops LLC | 16,107 | $150,000 | 0.00% |